Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study

Östör, A., Feist, E., Sidiropoulos, P. et al. (12 more authors) (Accepted: 2026) Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study. Rheumatology and Therapy. ISSN: 2198-6584 (In Press)

Metadata

Item Type: Article
Authors/Creators:
  • Östör, A.
  • Feist, E.
  • Sidiropoulos, P.
  • Avouac, J.
  • Rebella, M.
  • Namas, R.
  • Buttgereit, F.
  • Conaghan, P. ORCID logo https://orcid.org/0000-0002-3478-5665
  • Romero, A.B.
  • McDearmon-Blondell, E.L.
  • Lagunes-Galindo, I.
  • Gao, T.
  • Kadakia, A.
  • Shaw, T.
  • Attar, S.
Dates:
  • Accepted: 20 January 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 02 Feb 2026 11:26
Last Modified: 02 Feb 2026 11:26
Status: In Press
Publisher: Springer
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)